Subcutaneous Drug Delivery Devices Market
完整報告名稱與涵蓋範圍
Subcutaneous Drug Delivery Devices Market Size, Share & Trends Analysis Distribution by Product (Prefilled Syringes, Pen Injectors, Auto Injectors, Wearable Injectors, Needle-free Injectors), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Segment Forecasts, 2024-2031
報告摘要
The worldwide Subcutaneous Drug Delivery Devices Market stood at USD 30.9 Bn in 2023, and is projected to reach USD 55.7 Bn by 2031, recording a CAGR of 7.9% from 2024 through 2031.
The Subcutaneous Drug Delivery Devices sector involves specific systems designed to deliver drugs directly into the subcutaneous tissue, that is, just below the skin. This domain has witnessed marked transformation owing to technological breakthroughs and shifting healthcare dynamics.
Market momentum is propelled by rising need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold marked shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Subcutaneous Drug Delivery Devices Market Snapshot
Chapter 4. Global Subcutaneous Drug Delivery Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Subcutaneous Drug Delivery Devices Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Subcutaneous Drug Delivery Devices Industry Trends
Chapter 5. Subcutaneous Drug Delivery Devices Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product:
5.2.1. Prefilled syringes
5.2.2. Pen injectors
5.2.3. Auto injectors
5.2.4. Wearable injectors
5.2.5. Needle-free Injectors
Chapter 6. Subcutaneous Drug Delivery Devices Market Segmentation 2: By Distribution Channel, Estimates & Trend Analysis
6.1. Market Share by Distribution Channel, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Distribution Channels:
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
Chapter 7. Subcutaneous Drug Delivery Devices Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. Global Subcutaneous Drug Delivery Devices Market, Regional Snapshot 2023 & 2031
7.2. North America
7.2.1. North America Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.2.1.1. US
7.2.1.2. Canada
7.2.2. North America Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.2.3. North America Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
7.3. Europe
7.3.1. Europe Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.3.1.1. Germany
7.3.1.2. U.K.
7.3.1.3. France
7.3.1.4. Italy
7.3.1.5. Spain
7.3.1.6. Rest of Europe
7.3.2. Europe Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.3.3. Europe Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
7.4. Asia Pacific
7.4.1. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.4.1.1. India
7.4.1.2. China
7.4.1.3. Japan
7.4.1.4. Australia
7.4.1.5. South Korea
7.4.1.6. Hong Kong
7.4.1.7. Southeast Asia
7.4.1.8. Rest of Asia Pacific
7.4.2. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.4.3. Asia Pacific Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2024-2031
7.5. Latin America
7.5.1. Latin America Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
7.5.1.1. Brazil
7.5.1.2. Mexico
7.5.1.3. Rest of Latin America
7.5.2. Latin America Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.5.3. Latin America Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
7.6. Middle East & Africa
7.6.1. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.6.1.1. GCC Countries
7.6.1.2. Israel
7.6.1.3. South Africa
7.6.1.4. Rest of Middle East and Africa
7.6.2. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
7.6.3. Middle East & Africa Subcutaneous Drug Delivery Devices Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Gerresheimer AG
8.2.1.1. Business Overview
8.2.1.2. Key Product/Service Offerings
8.2.1.3. Financial Performance
8.2.1.4. Geographical Presence
8.2.1.5. Recent Developments with Business Strategy
8.2.2. Medtronic Plc
8.2.3. Ypsomed AG
8.2.4. Elcam Medical Group
8.2.5. Novo Nordisk
8.2.6. Insulet Corporation
8.2.7. Becton, Dickinson and Company
8.2.8. West Pharmaceutical Services, Inc.
8.2.9. PharmaJet
8.2.10. Unilife Corporation
8.2.11. Inolife Sciences
8.2.12. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們